Camlipixant showed significant efficacy in patients with higher baseline cough frequency, despite not meeting the primary endpoint in the overall population. The trial demonstrated camlipixant's ...

Nalbuphine extended release (ER) significantly reduces cough frequency and severity in patients with idiopathic pulmonary fibrosis (IPF), especially at higher doses, compared with placebo. The trial ...

Please provide your email address to receive an email when new articles are posted on . Patients with idiopathic pulmonary fibrosis coughed fewer times per hour after receiving a 14-day morphine ...

Cough imposed a substantial symptom burden in patients with hypersensitivity pneumonitis (HP). Corticosteroid therapy over 3 months was tied to reduced patient-reported cough severity and improved ...